Democrats such as Elizabeth Warren had their eye on business and the working class during the first 2020 presidential primary debate in Miami.2020 Electionsread more
The issue over health insurance marked the first stark divide among the candidates, and sparked a heated back-and-forth between many of the candidates on stage.Politicsread more
Huawei's legal chief told CNBC that the company makes "solutions for civil use."Technologyread more
Four candidates mentioned China — but none of the Democratic contenders brought up trade in the debate.Politicsread more
In a strategy to draw attention away from Wednesday's Democratic debate, President Donald Trump's reelection campaign bought out YouTube's "masthead," the leading...2020 Electionsread more
The Federal Aviation Administration said on Wednesday that is has found an issue with the Boeing 737 Max that the manufacturer must address before it lifts the grounding...Airlinesread more
The collapse of the deal potentially ended Sinclair's hopes of building a national conservative-leaning TV powerhouse that might have rivaled Fox News.Mediaread more
Huawei legal chief Song Liuping told CNBC that the company is in the "early phase" of talks with Verizon over paying royalties.Technologyread more
Virginia Sen. Mark Warner breaks down the idea behind a bipartisan bill he introduced to provide more transparency in Big Tech.Technologyread more
Tesla is working on new battery cell designs, and a way to make their own cells, with R&D teams in a lab near its car plant in Fremont, California.Technologyread more
Wi-Fi 6 will be the next-generation wireless standard. Along with 5G, it will represent the next big shift in connectivity and data, said Irving Tan, senior vice president and...Shaping the futureread more
A blood pressure app downloaded by tens of thousands of people before sales halted last year gave many patients with hypertension the false impression that their vital signs were normal when in reality they were dangerously high, a U.S. study suggests.
The app in question, Instant Blood Pressure from AuraLife, was designed to estimate blood pressure by placing the top edge of a smartphone on the left side of the chest and holding the right index finger over the camera on the device.
But approximately four out of every five people with hypertension got inaccurate readings from the app that suggested their blood pressure was in a normal range when it was actually high, the study found.
"If Instant Blood Pressure worked, it would be a revolutionary new technology that would allow for low-cost screening and management of hypertension among smartphone users," said lead study author Dr. Timothy Plante of Johns Hopkins University in Baltimore.
"That it doesn't use a cuff is neat as folks don't generally like carrying around a bulky blood pressure monitor," Plante added by email. "Inaccurate measurements for high or low readings are concerning, however. Hypertension is known as the silent killer as it has an asymptomatic course that leads to serious conditions like heart disease, kidney disease, and stroke."
At least 148,000 copies of the app were sold for $4.99 from June 2014 to July 2015, Plante and colleagues estimate in JAMA Cardiology.To test how well the app worked, the research team used the same standards new blood pressure cuffs must meet to win U.S. regulatory approval for use in doctors' offices.
They enlisted 85 volunteers, more than half with a diagnosis of hypertension and nearly all on medications for the condition.Researchers checked blood pressure twice with the app, following the instructions provided by the developer, and then compared the average result from those two readings to a separate measurement from a traditional blood pressure cuff.
Healthy people have a systolic blood pressure, the measurement when the heart beats, of less than 120 mmHg, and diastolic pressure, when the heart rests, of less than 80 mmHg. Blood pressure above 140 mmHg systolic or 90 mmHg diastolic are considered hypertension.
The average differences between the app results and the traditional cuff were 12.4 mmHg for systolic blood pressure and 10.1 mmHg for diastolic blood pressure.Generally, the app overestimated low blood pressure and underestimated hypertension.
It's hard to imagine any mobile app to measure blood pressure without a hardware component that does the job of a cuff, said Dr. Beverly Green, a researcher at Group Health Research Institute in Seattle who wasn't involved in the study.
"I am not an engineer, but from what I understand, you need a cuff (the thing that wraps around your arm and is pumped up) preferably on the upper arm, to get an accurate BP," Green said by email.
"The cuff compresses the arteries and measures the amount of pressure the heart needs to get blood out to the arteries and the pressure of the arteries when the heart is relaxed," Green added.
The app was available in both Apple's App Store and Google Play. Even though it's no longer sold, it's possible some users still have it on their phones. Apple confirmed the app was rejected, while Google declined to comment.
Ryan Archdeacon, CEO and co-founder of AuraLife, told Reuters Health by email that several issues with the study "render it invalid." Among these, multiple updates to the app during the study period and afterward improved the accuracy of readings by 30 percent, according to Archdeacon.
Moreover, the app was not designed to measure blood pressure above 158 mmHg systolic or 99 mmHg diastolic, he said. "Instant Blood Pressure is not a medical device and is not intended to diagnose disease, including hypertension," Archdeacon said.
Apps have potential to help more than 1 billion patients with hypertension worldwide manage their condition, though the findings highlight the pitfalls of consumers using a nascent technology, said Nilay Kumar, a researcher at Harvard University who wasn't involved in the study.
"While the promise of mobile health in revolutionizing hypertension treatment is enormous, BP measurement using a smartphone is still in its developmental stages," Kumar said by email.
SOURCE: http://bit.ly/21HSUz5 JAMA Internal Medicine, online March 2, 2016.(c) Copyright Thomson Reuters 2016. Click For Restrictions - http://about.reuters.com/fulllegal.asp